These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 34297718)
1. Machine learning reveals mesenchymal breast carcinoma cell adaptation in response to matrix stiffness. Rozova VS; Anwer AG; Guller AE; Es HA; Khabir Z; Sokolova AI; Gavrilov MU; Goldys EM; Warkiani ME; Thiery JP; Zvyagin AV PLoS Comput Biol; 2021 Jul; 17(7):e1009193. PubMed ID: 34297718 [TBL] [Abstract][Full Text] [Related]
2. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin. Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639 [TBL] [Abstract][Full Text] [Related]
3. Extracellular Matrix Alterations in Metastatic Processes. Paolillo M; Schinelli S Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31591367 [TBL] [Abstract][Full Text] [Related]
4. The monoamine oxidase-A inhibitor clorgyline promotes a mesenchymal-to-epithelial transition in the MDA-MB-231 breast cancer cell line. Satram-Maharaj T; Nyarko JN; Kuski K; Fehr K; Pennington PR; Truitt L; Freywald A; Lukong KE; Anderson DH; Mousseau DD Cell Signal; 2014 Dec; 26(12):2621-32. PubMed ID: 25152370 [TBL] [Abstract][Full Text] [Related]
5. Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition. Chao YL; Shepard CR; Wells A Mol Cancer; 2010 Jul; 9():179. PubMed ID: 20609236 [TBL] [Abstract][Full Text] [Related]
6. Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition. Su CM; Lee WH; Wu AT; Lin YK; Wang LS; Wu CH; Yeh CT J Nutr Biochem; 2015 Jun; 26(6):675-85. PubMed ID: 25792283 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of phosphatidylcholine-specific phospholipase C results in loss of mesenchymal traits in metastatic breast cancer cells. Abalsamo L; Spadaro F; Bozzuto G; Paris L; Cecchetti S; Lugini L; Iorio E; Molinari A; Ramoni C; Podo F Breast Cancer Res; 2012 Mar; 14(2):R50. PubMed ID: 22429397 [TBL] [Abstract][Full Text] [Related]
8. Vimentin contributes to epithelial-mesenchymal transition cancer cell mechanics by mediating cytoskeletal organization and focal adhesion maturation. Liu CY; Lin HH; Tang MJ; Wang YK Oncotarget; 2015 Jun; 6(18):15966-83. PubMed ID: 25965826 [TBL] [Abstract][Full Text] [Related]
9. MAGE-A is frequently expressed in triple negative breast cancer and associated with epithelial-mesenchymal transition. Wang H; Sang M; Geng C; Liu F; Gu L; Shan B Neoplasma; 2016; 63(1):44-56. PubMed ID: 26639233 [TBL] [Abstract][Full Text] [Related]
10. Epithelial-mesenchymal transition in breast epithelial cells treated with cadmium and the role of Snail. Wei Z; Shan Z; Shaikh ZA Toxicol Appl Pharmacol; 2018 Apr; 344():46-55. PubMed ID: 29501589 [TBL] [Abstract][Full Text] [Related]
11. Antrodia camphorata inhibits epithelial-to-mesenchymal transition by targeting multiple pathways in triple-negative breast cancers. Hseu YC; Chang GR; Pan JY; Rajendran P; Mathew DC; Li ML; Liao JW; Chen WT; Yang HL J Cell Physiol; 2019 Apr; 234(4):4125-4139. PubMed ID: 30146779 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-19 triggers epithelial-mesenchymal transition of lung cancer cells accompanied by growth inhibition. Li J; Yang S; Yan W; Yang J; Qin YJ; Lin XL; Xie RY; Wang SC; Jin W; Gao F; Shi JW; Zhao WT; Jia JS; Shen HF; Ke JR; Liu B; Zhao YQ; Huang WH; Yao KT; Li DJ; Xiao D Lab Invest; 2015 Sep; 95(9):1056-70. PubMed ID: 26098000 [TBL] [Abstract][Full Text] [Related]
13. A role for cancer-associated fibroblasts in inducing the epithelial-to-mesenchymal transition in human tongue squamous cell carcinoma. Zhou B; Chen WL; Wang YY; Lin ZY; Zhang DM; Fan S; Li JS J Oral Pathol Med; 2014 Sep; 43(8):585-92. PubMed ID: 24645915 [TBL] [Abstract][Full Text] [Related]
15. Bovine lactoferrin reverses programming of epithelial-to-mesenchymal transition to mesenchymal-to-epithelial transition in oral squamous cell carcinoma. Chea C; Miyauchi M; Inubushi T; Okamoto K; Haing S; Nguyen PT; Imanaka H; Takata T Biochem Biophys Res Commun; 2018 Dec; 507(1-4):142-147. PubMed ID: 30415774 [TBL] [Abstract][Full Text] [Related]
16. Serum amyloid A1: Innocent bystander or active participant in cell migration in triple-negative breast cancer? Olivier DW; Pretorius E; Engelbrecht AM Exp Cell Res; 2021 Sep; 406(1):112759. PubMed ID: 34332984 [TBL] [Abstract][Full Text] [Related]
17. Fluidity of Poly (ε-Caprolactone)-Based Material Induces Epithelial-to-Mesenchymal Transition. Mano SS; Uto K; Ebara M Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32143443 [TBL] [Abstract][Full Text] [Related]
18. Cofilin-1 signaling mediates epithelial-mesenchymal transition by promoting actin cytoskeleton reorganization and cell-cell adhesion regulation in colorectal cancer cells. Sousa-Squiavinato ACM; Rocha MR; Barcellos-de-Souza P; de Souza WF; Morgado-Diaz JA Biochim Biophys Acta Mol Cell Res; 2019 Mar; 1866(3):418-429. PubMed ID: 30296500 [TBL] [Abstract][Full Text] [Related]
19. IL-6 Impairs the Activity of Vitamin D3 in the Regulation of Epithelial-Mesenchymal Transition in Triple Negative Breast Cancer. Abdel-Mohsen MA; Abo Deif SM; Abou-Shamaa LA Asian Pac J Cancer Prev; 2019 Aug; 20(8):2267-2273. PubMed ID: 31450894 [TBL] [Abstract][Full Text] [Related]
20. Molecular Pathways Mediating Metastases to the Brain via Epithelial-to-Mesenchymal Transition: Genes, Proteins, and Functional Analysis. Jeevan DS; Cooper JB; Braun A; Murali R; Jhanwar-Uniyal M Anticancer Res; 2016 Feb; 36(2):523-32. PubMed ID: 26851006 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]